Ledger.Open graph →
SEC Form D · filed May 29, 2019

Asklepios BioPharmaceutical, Inc

Offering
$199.7M
Sold
$199.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Timothy Ferguson · Durham, NCExecSheila Mikhail · Research Triangle Park, NCExec · DirectorRichard Samulski · Durham, NCExec · DirectorWilliam Hawkins · Durham, NCDirectorJon Salveson · Louisville, CODirectorKatherine Wood · Durham, NCDirectorFred Cohen · Menlo Park, CADirectorJavier Garcia · Durham, NCDirectorJohn Schilling · FORT WORTH, TXDirectorWilliam Hawkins · Durham, NCDirectorJon Salveson · Louisville, CODirectorKatherine Wood · Durham, NCDirectorFred Cohen · Menlo Park, CADirectorJavier Garcia · Cambridge, MADirectorJohn Schilling · FORT WORTH, TXDirectorTimothy Ferguson · Durham, NCExecSheila Mikhail · Research Triangle Park, NCExec · DirectorRichard Samulski · Durham, NCExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗